Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mucopolysaccharidosis Type IIIA (MPS IIIA) Disease Monitoring Program

NCT07855562 is registered in ClinicalTrials.gov with Ultragenyx Pharmaceutical Inc as lead sponsor.

NCT NCT07855562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07855562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mucopolysaccharidosis Type IIIA (MPS IIIA) Disease Monitoring Program
Lead sponsor
Ultragenyx Pharmaceutical Inc
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
October 31, 2038
Enrollment
55 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mps iiia, mucopolysaccharidosis iii, sanfilippo a, sanfilippo syndrome